University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 20 of 21
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938
Effects of ASA on Prostate Tissue
NCT00234299
Local Warming of Surgical Incisions
NCT01026259
Managing Temporomandibular Disorder (TMD) Symptoms
NCT00237042
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
NCT00241748
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
NCT00425672
NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
NCT00229593
Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain
NCT00701571
Prazosin Alcohol Dependence IVR Study
NCT00167687
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease
NCT00183378
IC14 Antibodies to Treat Individuals With Acute Lung Injury
NCT00233207
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
NCT00194792
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00227539
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
NCT00194532
Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)
NCT00194649
Colorectal Cancer Screening Intervention in UWPN Clinics
NCT00161460
MY PALS: A Community-Based Physical Activity Support Program for Older Adults
NCT00132288
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
NCT00357448
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer
NCT00167648
TRADE-Testosterone Replacement and Dutasteride Effectiveness
NCT00194675
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421
Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
NCT00194558
Telephone Intervention After Traumatic Brain Injury
NCT00483522
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
NCT00156650
Pedestrian Behavior Following Implementation of a Walking School Bus
NCT00402701
Improving Firearm Storage in Alaska Native Villages
NCT00643812
Effects of Valerian on Sleep in Healthy Older Adults
NCT00097604
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer
NCT00238147
The Effects of Testosterone on Prostate Tissue (ACYP-1)
NCT00161486
Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III
NCT00194597
Evaluation of DBT Compared to Drug Counseling for Opiate Addicts
NCT00117741
AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)
NCT00120965
Male Hormonal Contraceptive Development-ACY-5
NCT00161447
Performance Evaluation and Research for Older Adults Requiring Major Surgery
NCT00487890
The Effect of Exercise on Mood After Traumatic Brain Injury
NCT00571545
Treatment of Suicidal Women With Borderline Personality Disorder
NCT00183651
HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1
NCT00084175
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
NCT00343109
Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia
NCT00520455
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
NCT00255866
Health Behavior Feedback Study for Veterans With Hepatitis C
NCT00229580
Yakima Head Start Fluoride Varnish Study
NCT00067353
Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury
NCT00483444
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
NCT00194779
Telehealth for Diabetes Self-Management
NCT00194805
Post-Hospital Case Management to Improve Clinical Outcomes in Individuals Requiring Mechanical Ventilation
NCT00149513
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
NCT00194402
Indicated Prevention With At-Risk Gamblers
NCT00078273
Asacol Dosing Study for Active Ulcerative Colitis
NCT00194818
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
NCT00228358
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.